Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 2801 | 40.615 |
09:33 ET | 4005 | 40 |
09:35 ET | 2434 | 40.02 |
09:37 ET | 5833 | 39.825 |
09:39 ET | 4442 | 40.155 |
09:42 ET | 4057 | 39.8 |
09:44 ET | 2200 | 39.82 |
09:46 ET | 13705 | 40.065 |
09:48 ET | 7439 | 40.505 |
09:50 ET | 2450 | 40.79 |
09:51 ET | 2618 | 40.65 |
09:53 ET | 4644 | 40.545 |
09:55 ET | 5387 | 40.43 |
09:57 ET | 2200 | 40.33 |
10:00 ET | 2540 | 40.31 |
10:02 ET | 1895 | 40.36 |
10:04 ET | 2599 | 40.19 |
10:06 ET | 2030 | 40.04 |
10:08 ET | 1200 | 40.09 |
10:09 ET | 2979 | 40 |
10:11 ET | 2500 | 40.02 |
10:13 ET | 5934 | 40.13 |
10:15 ET | 1722 | 40.05 |
10:18 ET | 500 | 40.1 |
10:20 ET | 13563 | 39.885 |
10:22 ET | 2690 | 39.913 |
10:24 ET | 12167 | 39.95 |
10:26 ET | 6422 | 39.93 |
10:27 ET | 10583 | 39.94 |
10:29 ET | 1393 | 39.96 |
10:31 ET | 6711 | 39.92 |
10:33 ET | 4592 | 39.92 |
10:36 ET | 9518 | 39.74 |
10:38 ET | 1751 | 39.76 |
10:40 ET | 38008 | 39.87 |
10:42 ET | 27349 | 39.81 |
10:44 ET | 9449 | 39.87 |
10:45 ET | 11039 | 39.61 |
10:47 ET | 11167 | 39.58 |
10:49 ET | 17096 | 39.62 |
10:51 ET | 50708 | 39.36 |
10:54 ET | 28210 | 39.48 |
10:56 ET | 12289 | 39.75 |
10:58 ET | 13905 | 39.75 |
11:00 ET | 5077 | 39.65 |
11:02 ET | 6653 | 39.73 |
11:03 ET | 2700 | 39.65 |
11:05 ET | 2100 | 39.75 |
11:07 ET | 1300 | 39.76 |
11:09 ET | 8838 | 39.5 |
11:12 ET | 1600 | 39.46 |
11:14 ET | 4125 | 39.54 |
11:16 ET | 4020 | 39.585 |
11:18 ET | 1585 | 39.585 |
11:20 ET | 3388 | 39.585 |
11:21 ET | 6821 | 39.49 |
11:23 ET | 1000 | 39.49 |
11:25 ET | 1257 | 39.5 |
11:27 ET | 5909 | 39.55 |
11:30 ET | 400 | 39.48 |
11:32 ET | 5294 | 39.515 |
11:34 ET | 7180 | 39.525 |
11:36 ET | 300 | 39.52 |
11:38 ET | 700 | 39.52 |
11:39 ET | 4666 | 39.59 |
11:41 ET | 1205 | 39.57 |
11:43 ET | 5620 | 39.46 |
11:45 ET | 11544 | 39.33 |
11:48 ET | 1450 | 39.33 |
11:50 ET | 9028 | 39.315 |
11:52 ET | 4100 | 39.25 |
11:54 ET | 7422 | 39.225 |
11:56 ET | 13184 | 39.105 |
11:57 ET | 12654 | 39.115 |
11:59 ET | 7821 | 39.03 |
12:01 ET | 16905 | 39.01 |
12:03 ET | 8415 | 38.99 |
12:06 ET | 900 | 38.99 |
12:08 ET | 2042 | 38.9865 |
12:10 ET | 2800 | 38.895 |
12:12 ET | 10229 | 38.89 |
12:14 ET | 5568 | 38.845 |
12:15 ET | 1516 | 38.86 |
12:17 ET | 19550 | 38.93 |
12:19 ET | 8572 | 39.055 |
12:21 ET | 7541 | 39.1 |
12:24 ET | 17811 | 39.22 |
12:26 ET | 7381 | 39.09 |
12:28 ET | 2710 | 39.06 |
12:30 ET | 2200 | 38.97 |
12:32 ET | 117476 | 38.96 |
12:33 ET | 6615 | 38.885 |
12:35 ET | 6987 | 39.065 |
12:37 ET | 45816 | 39.04 |
12:39 ET | 65083 | 39.11 |
12:42 ET | 18121 | 39.17 |
12:44 ET | 16051 | 39.15 |
12:46 ET | 29281 | 39.44 |
12:48 ET | 300 | 39.46 |
12:50 ET | 400 | 39.44 |
12:51 ET | 5900 | 39.26 |
12:53 ET | 501 | 39.24 |
12:55 ET | 100586 | 39.06 |
12:57 ET | 1400 | 39.03 |
01:00 ET | 6791 | 39.2755 |
01:02 ET | 11715 | 39.05 |
01:04 ET | 11066 | 39.075 |
01:06 ET | 2626 | 39.24 |
01:09 ET | 200 | 39.27 |
01:11 ET | 800 | 39.29 |
01:13 ET | 5785 | 39.43 |
01:15 ET | 2600 | 39.4798 |
01:18 ET | 5426 | 39.32 |
01:20 ET | 3300 | 39.35 |
01:22 ET | 1273 | 39.395 |
01:24 ET | 2300 | 39.39 |
01:26 ET | 2201 | 39.29 |
01:27 ET | 2624 | 39.3 |
01:29 ET | 1027 | 39.265 |
01:31 ET | 866 | 39.265 |
01:33 ET | 2300 | 39.335 |
01:36 ET | 4545 | 39.28 |
01:38 ET | 700 | 39.315 |
01:40 ET | 2600 | 39.33 |
01:42 ET | 10393 | 39.4107 |
01:44 ET | 604 | 39.39 |
01:45 ET | 1686 | 39.37 |
01:47 ET | 2192 | 39.3615 |
01:49 ET | 6939 | 39.3 |
01:51 ET | 1200 | 39.38 |
01:54 ET | 4327 | 39.32 |
01:56 ET | 600 | 39.28 |
01:58 ET | 1519 | 39.26 |
02:00 ET | 1700 | 39.285 |
02:02 ET | 1510 | 39.255 |
02:03 ET | 19068 | 39.19 |
02:05 ET | 4362 | 39.15 |
02:07 ET | 4700 | 39.275 |
02:09 ET | 2195 | 39.24 |
02:12 ET | 3400 | 39.24 |
02:14 ET | 11588 | 39.23 |
02:16 ET | 2700 | 39.2 |
02:18 ET | 3940 | 39.11 |
02:20 ET | 2300 | 39.115 |
02:21 ET | 3639 | 39.12 |
02:23 ET | 900 | 39.15 |
02:25 ET | 8601 | 39.34 |
02:27 ET | 1872 | 39.37 |
02:30 ET | 153364 | 39.3 |
02:32 ET | 18736 | 39.25 |
02:34 ET | 7357 | 39.22 |
02:36 ET | 9842 | 39.25 |
02:38 ET | 1300 | 39.28 |
02:39 ET | 4398 | 39.265 |
02:41 ET | 2262 | 39.27 |
02:43 ET | 829 | 39.24 |
02:45 ET | 5974 | 39.24 |
02:48 ET | 18177 | 39.215 |
02:50 ET | 802 | 39.24 |
02:52 ET | 977 | 39.24 |
02:54 ET | 4544 | 39.255 |
02:56 ET | 6458 | 39.385 |
02:57 ET | 4147 | 39.355 |
02:59 ET | 13822 | 39.25 |
03:01 ET | 2608 | 39.24 |
03:03 ET | 1794 | 39.3 |
03:06 ET | 5167 | 39.325 |
03:08 ET | 4798 | 39.37 |
03:10 ET | 1100 | 39.395 |
03:12 ET | 4438 | 39.34 |
03:14 ET | 1300 | 39.335 |
03:15 ET | 7228 | 39.305 |
03:17 ET | 2559 | 39.305 |
03:19 ET | 5790 | 39.36 |
03:21 ET | 3938 | 39.29 |
03:24 ET | 2300 | 39.23 |
03:26 ET | 4947 | 39.24 |
03:28 ET | 34237 | 39.49 |
03:30 ET | 4883 | 39.42 |
03:32 ET | 7943 | 39.405 |
03:33 ET | 5050 | 39.37 |
03:35 ET | 8235 | 39.395 |
03:37 ET | 30142 | 39.475 |
03:39 ET | 3436 | 39.49 |
03:42 ET | 14740 | 39.525 |
03:44 ET | 11478 | 39.49 |
03:46 ET | 5076 | 39.485 |
03:48 ET | 60524 | 39.525 |
03:50 ET | 9305 | 39.735 |
03:51 ET | 16729 | 39.58 |
03:53 ET | 12316 | 39.65 |
03:55 ET | 38851 | 39.945 |
03:57 ET | 58579 | 39.9 |
04:00 ET | 271040 | 40.03 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 7.4B | -25.5x | --- |
Ascendis Pharma A/S | 7.5B | -13.4x | --- |
Blueprint Medicines Corp | 6.4B | -47.8x | --- |
Viking Therapeutics Inc | 7.6B | -73.1x | --- |
Madrigal Pharmaceuticals Inc | 7.6B | -14.0x | --- |
ADMA Biologics Inc | 5.3B | 160.9x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.4B |
---|---|
Revenue (TTM) | $456.0M |
Shares Outstanding | 184.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.08 |
EPS | $-1.57 |
Book Value | $6.88 |
P/E Ratio | -25.5x |
Price/Sales (TTM) | 16.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.